Continuous active state of coagulation system in patients with nonthrombotic inflammatory bowel disease

Clinical and Applied Thrombosis/Hemostasis

Volumn 17, Issue 6, 2011, Pages 600-604

  Alkim, Huseyin ^a   Ayaz, Selime ^b   Alkim, Canan ^c   Ulker, Aysel ^b   Sahin, Burhan ^b  

^a BAKIRKOY DR SADI KONUK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b Turkey High Specialty Hospital   (Turkey)

^c SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

coagulation; Crohn disease; fibrinolysis; inflammatory bowel disease; ulcerative colitis

Indexed keywords

ANTIPLASMIN; ANTITHROMBIN; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; D DIMER; FIBRINOGEN; FIBRINOGEN DEGRADATION PRODUCT; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C; PROTEIN S; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; ENTERITIS; FEMALE; FIBRINOGEN BLOOD LEVEL; FIBRINOLYSIS; HUMAN; HYPERCOAGULABILITY; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBIN TIME; THROMBOCYTE; ULCERATIVE COLITIS;

ADULT; BLOOD COAGULATION; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; FIBRINOLYSIS; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; THROMBOPHILIA;

EID: 84857207884     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029611405034     Document Type: Article

References (34)

1. Wakefield AJ, Dhillon AP, Rowles PM, Sawyer AM, Pittilo RM, Lewis AAM. Pathogenesis of Crohn's disease: multifocal gastrointestinal infraction. Lancet. 1989 ; 2 (8671). 1057-1062 (Pubitemid 19264073)
2. Juhlin L, Krause U, Shelley WB. Endotoxin-induced microclots in ulcerative colitis and Crohn's disease. Scand J Gastroenterol. 1980 ; 15 (3). 311-314 (Pubitemid 10124188)
3. Dhillon AP, Anthony A, Sim R, et al. Mucosal capillary thrombi in rectal biopsies. Histopathology. 1992 ; 21 (2). 127-133
4. Thompson NP, Wakefield AJ, Pounder RE. Inherited disorders of coagulation appear to protect against inflammatory bowel disease. Gastroenterology. 1995 ; 108 (4). 1011-1015
5. Papa A, Danese S, Gasbarrini A, Gasbarrini G. Potential therapeutic applications and mechanism of action of heparin in inflammatory bowel disease. Aliment Pharmacol Ther. 2000 ; 14 (11). 1403-1409
6. Bernstein CN, Blanchard JF, Houston DS, Wajda A. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost. 2001 ; 85 (3). 430-434 (Pubitemid 32233013)
7. Talbot RW, Heppell J, Dozois RR, Beart RW. Vascular complications of inflammatory bowel disease. Mayo Clin Proc. 1986 ; 61 (2). 140-145 (Pubitemid 16127025)
8. Graef V, Baggenstoss AH, Seaur WG. Venous thrombosis occurring in non-specific ulcerative colitis. Arch Intern Med. 1966 ; 117: 377-382
9. Miehsler W, Reinisch W, Valic E, et al. Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?. Gut. 2004 ; 53 (4). 542-548 (Pubitemid 38372979)
10. Rachmilewitz D. Coated mesalazine (5-aminosalycylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomized trial. BMJ. 1989 ; 298 (6666). 82-86 (Pubitemid 19032930)
11. Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet. 1980 ; 1 (8617). 514
12. Danese S, Papa A, Saibeni S, Repici A, Malesci A, Vecchi M. Inflammation and coagulation in inflammatory bowel disease: the clot thickens. Am J Gastroenterol. 2007 ; 102 (1). 174-186 (Pubitemid 46072059)
13. Solem CA, Loftus EV, Tremaine WJ, Sandborn WJ. Venous thromboembolism in inflammatory bowel disease. Am J Gastroenterol. 2004 ; 99 (1). 97-101 (Pubitemid 38679109)
14. Larsen TB, Nielsen JN, Fredholm L, et al. Platelets and anticoagulant capacity in patients with inflammatory bowel disease. Pathophysiol Haemost Thromb. 2002 ; 32 (2). 92-96 (Pubitemid 37490513)
15. Van Bodegraven AA, Schoorl M, Baak JP, Linskens RK, Bartels PC, Tunyman HA. Hemostatic imbalance in active and quiescent ulcerative colitis. Am J Gastroenterol. 2001 ; 96 (2). 487-493
16. Kume K, Yamasaki M, Tashiro M, Yoshikawa I, Otsuki M. Activations of coagulation and fibrinolysis secondary to bowel inflammation in patients with ulcerative colitis. Intern Med. 2007 ; 46 (17). 1323-1329
17. Stevens TR, James JP, Simmonds NJ, et al. Circulating von Willebrand factor in inflammatory bowel disease. Gut. 1992 ; 33 (4). 502-506
18. Zezos P, Papaioannou G, Nikolaidis N, Vasiliadis T, Giouleme O, Evgenidis N. Elevated plasma von Willebrand factor levels in patients with active ulcerative colitis reflect endothelial perturbation due to systemic inflammation. World J Gastroenterol. 2005 ; 11 (48). 7639-7645 (Pubitemid 43168429)
19. Saito H. Contact factors in health and disease. Semin Thromb Hemost. 1987 ; 13 (1). 36-49 (Pubitemid 17034602)
20. Hudson M, Chitolie A, Hutton RA, Smith MS, Pounder RE, Wakefield AJ. Thrombotic vascular risk factors in inflammatory bowel disease. Gut. 1996 ; 38 (5). 733-737 (Pubitemid 26167482)
21. Lee LC, Spittell JA, Sauer WG, Owen CA, Thompson JH. Hypercoagulability associated with chronic ulcerative colitis: changes in blood coagulation factors. Gastroenterology. 1968 ; 54 (1). 76-85
22. Lam A, Borda IT, Inwood MJ, Thomson S. Coagulation studies in ulcerative colitis and Crohn's disease. Gastroenterology. 1975 ; 68 (2). 245-251
23. Lake AM, Stauffer JQ, Stuart MJ. Hemostatic alterations in inflammatory bowel disease: response to therapy. Am J Dig Dis. 1978 ; 23 (10). 897-902 (Pubitemid 9039622)
24. Souto JC, Martinez E, Roca M, et al. Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease. Dig Dis Sci. 1995 ; 40 (9). 1883-1889
25. Kjeldsen J, Lassen JF, Brandslund I, Schaffalitzky de Muckadell OB. Markers of coagulation and fibrinolysis as measures of disease activity in inflammatory bowel disease. Scand J Gastroenterol. 1998 ; 33 (6). 637-643 (Pubitemid 28300246)
26. Linskens RK, van Bodegraven AA, Schoorl M, Tunyman HA, Bartels P. Predictive value of inflammatory and coagulation parameters in the course of severe ulcerative colitis. Dig Dis Sci. 2001 ; 46 (3). 644-648 (Pubitemid 32299823)
27. van Bodegraven AA, Schoorl M, Linskens RK, Bartels PC, Tunyman HA. Persistent activation of coagulation and fibrinolysis after treatment of active ulcerative colitis. Eur J Gastroenterol Hepatol. 2002 ; 14 (4). 413-418 (Pubitemid 34439042)
28. Danese S, Papa A. PAI-1 and TAFI in inflammatory bowel disease: the yin and yang of the fibrinolytic system. Eur J Gastroenterol Hepatol. 2008 ; 20 (9). 826-828
29. Cesarman-Maus G, Hajjar KA. Molecular mechanisms of fibrinolysis. Br J Haematol. 2005 ; 129 (3). 307-321 (Pubitemid 40646889)
30. Koutroubakis IE, Sfiridaki A, Tsiolakidou G, Coucoutsi C, Theodoropoulou A, Kouroumalis EA. Plasma thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 levels in inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2008 ; 20 (9). 912-916
31. Hayat M, Ariens RA, Moayyeli P, Grant PJ, O'Mahony S. Coagulation factor XIII and markers of thrombin generation and fibrinolysis in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2002 ; 14 (3). 249-256 (Pubitemid 34259273)
32. van Bodegraven AA, Tunyman HA, Schoorl M, Kruishoop AM, Bartels PC. Fibrinolytic split products, fibrinolysis, and factor XIII activity in inflammatory bowel disease. Scand J Gastroenterol. 1995 ; 30 (6). 580-585
33. Chamouard P, Grunebaum L, Wiesel ML, et al. Prothrombin fragment 1+2 and thrombin-antithrombin III complex as markers of activation of blood coagulation in inflammatory bowel disease. Eur J Gastroenterol Hepatol. 1995 ; 7 (12). 1183-1188 (Pubitemid 26030853)
34. Deban L, Correale C, Vetrano S, Malesci A, Danese S. Multiple pathogenic roles of microvasculature in inflammatory bowel disease: a jack of all trades. Am J Pathol. 2008 ; 172 (6). 1457-1466 (Pubitemid 351793339)